Følg
Juergen Wasem
Tittel
Sitert av
Sitert av
År
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives
T Neumann, J Biermann, R Erbel, A Neumann, J Wasem, G Ertl, R Dietz
Deutsches Ärzteblatt International 106 (16), 269, 2009
3462009
Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
U Siebert, G Sroczynski, S Rossol, J Wasem, U Ravens-Sieberer, ...
Gut 52 (3), 425-432, 2003
2462003
Risk adjustment and risk selection on the sickness fund insurance market in five European countries
WPMM Van de Ven, K Beck, F Buchner, D Chernichovsky, L Gardiol, ...
Health policy 65 (1), 75-98, 2003
2262003
Empirical standard costs for health economic evaluation in Germany--a proposal by the working group methods in health economic evaluation
C Krauth, F Hessel, T Hansmeier, J Wasem, R Seitz, B Schweikert
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2005
1872005
Krankenhaus-Report 2013
J Klauber, M Geraedts, J Friedrich, J Wasem
Schattauer Verlag, 2013
186*2013
Risk adjustment and risk selection in Europe: 6 years later
WPMM Van de Ven, K Beck, C Van de Voorde, J Wasem, I Zmora
Health policy 83 (2-3), 162-179, 2007
1802007
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus
JM Graf von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, ...
Value in health 11 (4), 539-544, 2008
1582008
Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation-ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG)
C Krauth, F Hessel, T Hansmeier, J Wasem, R Seitz, B Schweikert
Das Gesundheitswesen 67 (10), 736-746, 2005
1552005
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger …
M Port, M Boettcher, F Thol, A Ganser, R Schlenk, J Wasem, A Neumann, ...
Annals of hematology 93, 1279-1286, 2014
1542014
Zur Wirkung des Risikostrukturausgleichs in der gesetzlichen Krankenversicherung: eine Untersuchung im Auftrag des Bundesministeriums für Gesundheit
K Jacobs, P Reschke, D Cassel, J Wasem
(Schriftenreihe des Bundesministeriums für Gesundheit; 140), 2002
1522002
Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation-dritte und aktualisierte Fassung des Hannoveraner Konsens
JMG von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, R Leidl, ...
Gesundheitsökonomie & Qualitätsmanagement 12 (05), 285-290, 2007
1372007
Consumer price sensitivity and social health insurer choice in Germany and the Netherlands
FT Schut, S Greß, J Wasem
International journal of health care finance and economics 3, 117-138, 2003
1362003
Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
WPMM Van de Ven, K Beck, F Buchner, E Schokkaert, FTE Schut, ...
Health policy 109 (3), 226-245, 2013
1342013
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk …
S Moebus, JU Hanisch, P Aidelsburger, P Bramlage, J Wasem, KH Jöckel
Cardiovascular Diabetology 6, 1-10, 2007
1322007
Free choice of sickness funds in regulated competition: evidence from Germany and the Netherlands
S Greß, P Groenewegen, J Kerssens, B Braun, J Wasem
Health policy 60 (3), 235-254, 2002
1242002
Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community
B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ...
Pharmacoeconomics 34, 227-244, 2016
1192016
Needs for further improvement: risk adjustment in the German health insurance system
F Buchner, J Wasem
Health Policy 65 (1), 21-35, 2003
1102003
Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
E Steinhagen-Thiessen, P Bramlage, C Lösch, H Hauner, H Schunkert, ...
Cardiovascular Diabetology 7, 1-11, 2008
1052008
Das Gesundheitswesen in Deutschland: Einstellungen und Erwartungen der Bevölkerung
J Wasem
Janssen-Cilag GmbH, Neuss, 1999
991999
Economic evaluation of treatment options in patients with Alzheimer’s disease: a systematic review of cost-effectiveness analyses
L Pouryamout, J Dams, J Wasem, R Dodel, A Neumann
Drugs 72, 789-802, 2012
982012
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20